Native low-density lipoproteins stimulate leukotriene B4 production by human monocyte-derived macrophages

Biochim Biophys Acta. 1991 Jun 3;1083(3):230-4. doi: 10.1016/0005-2760(91)90076-t.

Abstract

We have evaluated the effect of native low-density lipoproteins (LDL) on the production of leukotriene B4 (LTB4), a potent inflammatory and chemotactic factor, by human monocyte-derived macrophages. The capacity of LDL (d, 1.024-1.050 g/ml) to increase LTB4 secretion was dose-dependent with an optimal response at 100 micrograms LDL protein/ml, representing an approx. 7.5-fold stimulation over basal levels at 10 days of culture; the half-maximal response occurred at 20 micrograms/ml. The effect of LDL on LTB4 production was rapid (within 15 min) and was maintained for at least 21 h. The generation of LTB4 in response to LDL was partially inhibited (approx. 70% inhibition) by EDTA (5 mM) and by a monoclonal antibody (IgG-C7; 160 micrograms/ml) directed against the binding site of the cellular LDL receptor. In addition, the effects of native LDL and acetylated LDL were additive. These findings suggest that the specific interaction of LDL with its high affinity receptor represents a major component in the stimulation of the production of LTB4 by human monocyte-derived macrophages.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Edetic Acid / pharmacology
  • Humans
  • Leukotriene B4 / biosynthesis*
  • Lipoproteins, LDL / antagonists & inhibitors
  • Lipoproteins, LDL / pharmacology*
  • Macrophages / drug effects
  • Macrophages / metabolism*
  • Receptors, LDL / drug effects
  • Stimulation, Chemical

Substances

  • Antibodies, Monoclonal
  • Lipoproteins, LDL
  • Receptors, LDL
  • Leukotriene B4
  • Edetic Acid